In this article C RDW CTVA MRNA SAVE 9868-HK AAL 9866-HK ADBE F GM Follow your favorite stocksCREATE FREE ACCOUNT David Wadhwani, senior vice president of digital media for Adobe Systems, speaks during the launch of Adobe Creative Cloud and CS6 in San Francisco on April 23, 2012. David Paul Morris | Bloomberg | Getty
admin
It’s time to buy back into semiconductor stocks. With surging AI-centric advancements, and a potential quantum computing boom to boot, the industry is seeing a massive revival. For an idea of just how strong, look at the Vaneck Semiconductor ETF (NASDAQ:SMH). The ETF, which counts Nvidia (NASDAQ:NVDA) and Advanced Micro Devices (NASDAQ:AMD) as some of its biggest
As many remember, both in their minds and pockets, Brent crude prices reached a decade-high last year, impacting oil prices globally. In 2023, global crude prices thankfully moderated in the first half. But with both Saudi Arabia and Russia extending their oil production cuts until the end of the year and U.S. oil reserve figures
Lucid Group (NASDAQ:LCID) stock is one I’ve had mixed opinions of in the past. On the one hand, this is a company with some clear speculative upside, particularly as a vehicle for investors to bet on the overall electric vehicle space. However, it’s also clear that Lucid Group is one that has been plagued by
U.S. stock indexes were trading higher on Wednesday morning after the latest consumer-price index data showed inflation picked up in August, which could change expectations for the Federal Reserve’s interest-rate policy. How are stock indexes trading The S&P 500 SPX rose 6 points, or 0.2%, to 4,468 The Dow Jones Industrial Average DJIA was up
Safra Catz, CEO of Oracle Corporation, rings the opening bell at the New York Stock Exchange (NYSE) in New York City, U.S., July 12, 2023. Brendan Mcdermid | Reuters Check out the companies making headlines before the bell Oracle – Shares fell 10% before the opening bell after the company posted weaker-than-expected revenue and revenue
It’s been a difficult time for biotechnology stocks. After a boom during the Covid-19 pandemic, the entire sector appears to have been abandoned by investors. The Standards and Practices (S&P) 500 Biotechnology Select Industry Index has declined 11% throughout the past 12 months and is down 18% throughout the last five years. Companies large and
While no participating entity in the capital markets is infallible, retail investors may nevertheless find comfort in targeting opportunities – or exiting from them as is the case here – based on unusual options activity. For this edition, we’ll be exploring stocks to sell based on the rumblings printed by the so-called smart money. To
Towards the end of 2021, Nvidia (NASDAQ:NVDA) stock was trading at $300. NVDA stock corrected to lows of $108 by October 2022 before skyrocketing by more than 200% for year-to-date. The point I want to make is that the rally in blue-chip stock can be stellar from oversold levels. It does not take time for
Central bankers love to steer the market, but the messages coming from European Central Bank officials on what they will do on Thursday are anything but crystal clear. Swaps trading imply a roughly one-in-three chance the ECB will hike interest rates from the deposit rate’s current 3.75%. That’s as the central bank has to balance
Traders work on the floor of the New York Stock Exchange, July 12, 2023. Brendan Mcdermid | Reuters Check out the companies making headlines in midday trading. Oracle — Shares dipped more than 12% a day after the software company posted disappointing earnings and revenue guidance for its fiscal second quarter. Oracle’s revenue, which came in at
Stocks are holding up well thus far in 2023 after a strong rally. However, historically, September is a challenging month for the market. Now may be a good time for investors to be selective and consider defensive stocks. Companies operating in defensive industries provide investors with relative safety due to many factors. These companies may
In a battle of the overpaid CEOs, Elon Musk recently made fun of Lucid Group (NASDAQ:LCID) CEO Peter Rawlinson for hauling in $379 million in 2022. Most of that was from options and stock awards vested during the year. As the Automotive News points out, you won’t be able to detect the superb pay from
“Social media is the ultimate equalizer. It gives a voice and a platform to anyone willing to engage.” –Amy Jo Martin This has not been a healthy market by any means. As I’ve noted numerous times, the vast majority of stocks have performed sub-par in what is otherwise supposed to be a strong year given
U.S. stocks opened lower Tuesday, as investors look to the widely anticipated reading on August inflation from the consumer-price index on Wednesday and traders kept their powder dry ahead of Apple’s marketing event. How stock indexes are trading The Dow Jones Industrial Average DJIA fell 50 points, or 0.1%, to around 34,614 The S&P 500
Visit our website: https://www.zacks.com Visit our Stocktwits account: https://stocktwits.com/ZacksResearch Check out our weekly promotion: https://www.zacks.com/promo If you’re interested in our services, please check out Zacks Ultimate: https://www.zacks.com/ultimate/?adid=YOUTUBE&cid=sm-YOUTUBE
Qualcomm CEO Cristiano Amon. Carlo Allegri | Reuters Check out the companies making headlines in premarket trading Monday. Tenable Holdings — The exposure management solutions provider rose 3% before the market opened following an upgrade to overweight from neutral at JPMorgan. The bank said the company is positioned to see better business fundamentals in the
Weight-loss drugs are taking the U.S. by storm. JPMorgan Chase (NYSE:JPM) is forecasting that the market for weight-loss medications could reach $100 billion in annual sales. The new class of drugs, known as “incretins,” has been shown in clinical trials to suppress appetite and reduce food intake. This, in turn, leads to dramatic weight loss
Some penny stocks go on to deliver huge returns for their owners. Most, however, do not. After all, companies usually end up in penny stock territory because something dramatic has gone wrong with their business model. At times, these issues can be resolved. In others, however, little chance of a revival exists due to a
In early August, I wrote about how shares of T2 Biosciences (NASDAQ:TTOO) could rise to $1 or more in a short-term frenzy. Meme investors had singled out the stock, and heavy options trading meant shares were at risk of getting squeezed. Retail investors delivered. Within two weeks, TTOO’s stock had risen from 30 cents to